Answers are grounded in this paper and cite their sources.
The immune microenvironment plays a pivotal role in bone defect repair, with macrophage polarization serving as a critical determinant of healing outcomes. Mitochondria, as essential organelles governing cellular energy metabolism, redox homeostasis, and signaling transduction, have emerged as central regulators of macrophage polarization. Mitochondrial quality control encompasses a series of coordinated processes including mitochondrial biogenesis, dynamics, metabolic reprogramming, reactive oxygen species (ROS) regulation, mitophagy, and intercellular mitochondrial transfer. Dysfunction in any of these processes can shift macrophage polarization toward the pro-inflammatory M1 phenotype, perpetuating chronic inflammation and impairing bone regeneration. In recent years, biomaterial-based strategies targeting mitochondrial function have gained considerable attention as promising approaches for immunomodulation in bone tissue engineering. This review comprehensively discusses the molecular mechanisms by which mitochondrial quality control processes regulate macrophage polarization, and systematically summarizes recent advances in biomaterial strategies that target these mitochondrial functions. We organize biomaterial approaches by their target mitochondrial mechanisms and further categorize them by material type, including metal ion-releasing biomaterials, nanoparticle-based systems, hydrogel platforms, and functionalized scaffolds. Furthermore, we discuss current challenges and future perspectives in developing next-generation immunomodulatory biomaterials that precisely target mitochondrial quality control for enhanced bone defect repair.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: